Reporter

February 3, 2022

Team to study using probiotics to reduce heart disease risk

A Vanderbilt research team has received a $7 million grant from the National Institutes of Health (NIH) to understand how alcohol’s effect on the gut microbiome drives heart disease.

February 3, 2022

Study finds shorter treatment better for young children with outpatient pneumonia

A Vanderbilt study found that five days of antibiotics is superior to 10 days for children with community-acquired pneumonia who are not hospitalized.

Travis Osterman, DO, MS, is working to establish common data standards for oncology clinicians and researchers.
February 3, 2022

Osterman plays key role in major oncology EHR initiative

Vanderbilt’s Travis Osterman, DO, MS, is leading an integral component of the Minimal Common Data Elements (mCODE) initiative, establishing common data standards for oncology clinicians and researchers.

The virtual Advanced Practice Grand Rounds focused on the experience of caring for COVID-19 patients for nearly two years.
February 3, 2022

Advanced Practice Grand Rounds explores COVID’s impact

The recent VUMC Advanced Practice Grand Rounds explored the impact the ongoing COVID-19 pandemic is having on the nursing workforce.

February 3, 2022

Events scheduled to raise funds for the Shade Tree Clinic

Several upcoming events are set to benefit the Shade Tree Clinic, which provides health care to Nashville’s uninsured community and is run by Vanderbilt medical and nursing students.

Corina Borza, PhD, left, Ambra Pozzi, PhD, and colleagues are studying a certain cell surface receptor’s role in the process that leads to kidney failure.
February 2, 2022

VUMC study raises hope for improving treatment of kidney disease

Vanderbilt research has revealed an important mechanism in the kidney by which a cell surface receptor known as DDR1 fans the flames of inflammation and fibrosis that ultimately lead to kidney failure.